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Introduction
Management of chronic wounds is a major challenge to soci-
ety because of its magnitude, complexity and cost. George
estimates that the worldwide prevalence of some leg ulcers is
8–10 million, and of pressure sores is 7–8 million.1
Many different types of dressings are recommended for the
management of chronic wounds. Traditional or conventional
dressings include gauze, gauze soaked in saline, tulle gras and
knitted viscose dressings. Winter, however, introduced the
concept of interactive dressings that can alter the local wound
environment, e.g. alginates, collagen films, foams, hyaluronic
acid products, hydrocolloids and hydrogels.2 These dressings
are occlusive or semi-occlusive and cause accumulation of
water vapour at the surface, which helps to maintain a moist
wound environment. These may also insulate the wound sur-
face from excessive heat loss, which is thought to inhibit
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fibroblast activity. In a more aggressive approach, active dress-
ings that have various properties believed to have a direct role
in changing the chemical and cellular make-up of the wound
have been developed. Examples of active dressings include
skin grafts, growth factors and cellular suspensions. Hy-
drocolloid dressing (HCD) is an occlusive dressing that con-
tains a hydrocolloid matrix (e.g. gelatin, pectin and carboxy-
methylcellulose) with elastomeric and adhesive substances
attached to a polymer base. On contact with wound exudates,
the hydrocolloid matrix absorbs water, swells and lique-
fies to form a moist gel. This has been claimed to expedite
healing by providing a moist and warm environment at the
wound surface and also by preventing external bacterial
colonization. Applying a dressing that is impermeable to bac-
teria reduces infection rates by 50%.3 The bacterial content of
wounds under occlusive dressings is less than that of similar
wounds treated with conventional absorbent materials, possi-
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bly because active phagocytic cells are retained at the moist
wound surface.4 In vitro studies show that relatively low oxygen
tension stimulates angiogenesis and fibroblast and epidermal
cell turnover and, therefore, is expected to provide good con-
ditions for wound healing.5 Many studies claim that HCD
leads to better healing, but most of these results are based on
small trials that show either marginal or no benefit.
To compare the effectiveness of HCD over conventional
gauze dressing, we carried out a meta-analysis of the existing
randomized controlled trials comparing HCD to conventional
gauze dressing in the healing of chronic wounds.
Materials and methods
We conducted electronic searches of MEDLINE for articles
published up to 2001. The search was carried out using all
possible combinations of the key words: hydrocolloid dressing,
paraffin gauze, duoderm, saline gauze, occlusive dressing and
conventional dressing. We reviewed all relevant articles found
in the searches. Reference lists of all articles were scanned to
identify additional articles that were not found in the compu-
terized bibliographic database search.
Studies were included if they were randomized controlled
trials published in English, included only chronic wounds,
clearly described the time to healing, and used HCD in one
treatment arm and conventional dressing such as paraffin
gauze or cotton gauze in another. Trials in patients with acute
wounds such as burns or skin graft donor sites, studies includ-
ing primary sutured surgical wounds, reports without data on
complete healing and crossover trials were excluded. Partial
healing or improvement in healing were considered in-
adequate because, from the patient’s point of view, complete
healing is more important than just improvement or percent-
age area healed.
Study quality was evaluated using six assessment crite-
ria (randomization, blinding, follow-up, whether pain was
quantified, whether cost was quantified, and comparability of
groups). Two independent reviewers studied the articles, com-
pleted data extraction forms separately for each article, and
scored each article according to the six criteria. There was
complete agreement between the two reviewers.
In addition to the references obtained from the electronic
search and cross references, one unpublished trial conducted
at our institution (Wound Clinic, Outpatient Department, All
India Institute of Medical Sciences) between 1994 and 1997
was also included (Srivastava A, et al. Duoderm occlusive hy-
drocolloid dressing versus paraffin gauze dressing in man-
agement of chronic venous ulcer: a randomized trial. Written
communication, January 2001). This randomized controlled
single-blinded study of chronic venous ulcers was supported
by ConvaTec Inc (Princeton, NJ, USA). A total of 100 partici-
pants were enrolled and randomized to receive either HCD or
paraffin gauze dressing.
Analysis
Two effect measures were used in the meta-analysis: the odds
ratio (OR) and the risk difference. These measures are defined
below.
If xt is the number of persons with outcomes observed in
the treatment group, xc is the number of persons with out-
comes observed in the control group, nt is the number of
persons in the treatment group, and nc is the number of
persons in the control group, then the proportion of the
outcomes in the two groups are given by pt and pc, respectively,
where pt = xt/nt and pc = xc/nc.
The OR measures the increased risk (benefit) of a treat-
ment compared with the control group. It is defined as the
ratio of the odds of occurrence of events in the treatment
group to the odds of occurrence of events in the control group.
If {pt/(1 – pt)} is the odds of occurrence of the event in the
experimental group and {pc/(1 – pc)} is the odds of occurrence
of the event in the control group, then OR = [pt/(1 – pt)]/
[pc/(1 – pc)]. For analysis purposes, we use log OR, for which
Variance = [1/ ntpt(1 – pt)] + [1/ncpc(1 – pc)].
The risk difference measures the increase in the proportion
of events in the treatment group compared with the control
group. It is the difference in the proportion of events in the
treatment group and the control group. Risk difference =
pt – pc, with Variance = [pt/(1 – pt)/nt] + [pc/(1 – pc)/nc].
The combined effect measure was obtained by applying
the fixed effect method and the random effect method. The
methods vary in their basic assumptions. The fixed effect
method is based on the assumption that the individual study
effects are homogeneous and whatever heterogeneity is ob-
served is due to the sampling errors of individual studies. The
random effect method incorporates the heterogeneity be-
tween studies as a separate component in addition to the
variation within studies. The combined fixed effect measure is
the weighted average of the individual effect measures, the
weights being the precision (inverse of variance) of the indi-
vidual studies. The combined random effect measure is also
the weighted average, but the weights are the inverse of the
sum of variance between studies and the variance within
studies. To decide which method should be used for the
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analysis, a Chi-squared test of heterogeneity is applied under
a prior assumption of homogeneity. If this test is statistically
significant, it is inferred that the studies have shown that they
differ significantly and a random effect model is appropriate.
However, if the test of heterogeneity is not statistically sig-
nificant, we assume that there is not enough evidence to re-
ject the assumption of homogeneity and a fixed effect model
would be adequate.
Results
Of the 83 articles found through the literature search, only 11
met the inclusion criteria. In the trial of Viciano et al,6 the
number of patients who achieved complete healing at the end
of 12 weeks was not given in the paper, so this information
was obtained from Dr. Vicente Viciano through personal,
written, communication (July–November 2001). The study
by Handfield-Jones et al was excluded because it was a cross-
over trial.7 Lindholm conducted only a cost-effectiveness
analysis and did not provide data on complete healing, so
this study was also excluded.8 The analysis was performed
both with and without the results from the unpublished
Srivastava et al study. The randomization method was not
mentioned in any of the articles except the unpublished Sri-
vastava et al article, in which randomization used sealed
opaque envelopes containing computer-generated random
numbers provided by ConvaTec Inc. Observers were only
blinded in the Alm et al study, which was a partially single-
blind trial.9 Some patient characteristics and methods of
dressing are highlighted in the Table.
Analysis
The number of completely healed ulcers was recorded from all
trials to compare the proportion of ulcers healed in the HCD
and conventional dressing groups. Figure 1 shows the Forrest
plot for all the trials included in the meta-analysis. A total of
819 ulcers (431 in the HCD group and 388 in the conventional
group) were studied. There was complete healing in 51% (221/
431) of ulcers in the HCD group compared to 38% (148/388)
in the conventional group. Of the 12 studies, that by Gorse
and Messner was the largest with 128 ulcers.10 This study
yielded an OR of 2.45, which was statistically significant (p =
0.02; 95% confidence interval, CI = 1.18, 5.12).
Four other studies showed a statistically significant ben-
eficial effect of HCD over conventional dressing: Alm et al,9
Colwell et al,14 Ohlsson et al15 and Srivastava et al (written
communication, January 2001). In the study by Colwell et al,
there was an unequal distribution of events in the two groups
and, hence, the result may not be realistic.14 The trial by
Ohlsson et al included only 28 patients, and the 95% CI (0.97,
37.30) shows unrealistically high limits due to the small sam-
ple size.15 The unpublished study by Srivastava et al yielded an
OR of 2.28, which was statistically significant according to
the heterogeneity test. Random effects modelling yielded an
OR of 1.73, equivalent to the fixed effect method but with a
broader 95% CI (1.08, 2.78). Analysis using risk difference
yielded similar results (Figure 2). Two large studies, by Gorse
and Messner10 and the unpublished Srivastava et al study,
yielded a 20% increase in the proportion of ulcers completely
healed by HCD compared to conventional dressing. Colwell
et al14 and Ohlsson et al15 reported significant benefits but,
as described above, these could not be realistic.
The analysis was repeated for both effect measures ex-
cluding the unpublished study. This yielded a combined OR
of 1.62 using the fixed effect approach, which was statisti-
cally significant (p = 0.01; 95% CI = 1.12, 2.37). The random
effect method yielded an OR of 1.67 (p = 0.06; 95% CI = 0.97,
2.88).
The trial by Colwell et al yielded an extremely beneficial
effect with HCD compared to conventional dressing (p =
0.002; OR = 14.27).14 Analysis excluding this trial yielded a
fixed effect combined OR of 1.63 (p = 0.005; 95% CI = 1.16,
2.29) and a random effect combined OR of 1.58 (p = 0.04; 95%
CI = 1.02, 2.46). The combined effect remained significant,
with HCD yielding a beneficial effect over conventional
dressing. When both the unpublished and Colwell et al14
studies were excluded, the fixed effect OR was 1.50 (95% CI =
1.04, 2.20), which was statistically significant.
Cost-effectiveness
Though the main aim of this meta-analysis was to measure
the proportion of complete healing with HCD compared to
conventional dressing, we also considered cost effectiveness
in the trials included in our meta-analysis.
Although cost was described in seven of 12 trials, the
factors included for calculating cost differed considerably.
Therefore, no statistical test was used to analyse cost-
effectiveness. In five trials, HCD was significantly cost effective
over conventional dressing.10,12,14,15,17 In the trial by Viciano et
al, there was no difference in cost.6 In the Hansson trial, to-
tal weekly cost was the same in both arms, but when average
cost per percentage surface area reduction was taken into
account, the cost of paraffin gauze dressing (US$12.90) was
substantially less than that of HCD (US$32.50).18
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Table. Characteristics of patients included in the meta-analysis
Study Year Place N n
M:F Age (yr), mean ( SD
CON Type of ulcer
HCD CON HCD CON
Gorse & Messner10 1987 USA 128 52 All male All male 72 ( 12.8 68.4 ( 13.5 Gauze in Dakin solution Pressure ulcer
Backhouse et al11 1987 UK 56 56 11:17 12:16 69.9 67.5 Porous non-adherent Venous ulcer
dressing with graduated
compression bandage
Alm et al9 1989 Sweden 56 56 1:3 (whole group)* 83.6 ( 9.2 83.4 ( 9.4 Saline gauze Pressure ulcer
Xakellis & 1992 USA 39 39 1:8 1:20 77.3 ( 16.9 83.5 ( 10.6 Two layers of Pressure ulcer
Chrischilles12 moistened gauze
Cordts et al13 1992 USA 43 43 NS NS NS NS Unna’s boot Venous leg ulcer
Colwell et al14 1993 USA 97 70 6:5 19:18 68 68 Moist gauze Pressure ulcer
Ohlsson et al15 1994 Sweden 28 28 26:4 (whole group)* Median: 77.6 Median: 73.5 Saline-soaked gauze Venous/mixed
venous arterial
leg ulcer
Arnold et al16 1994 USA 93 70 13:12 (whole group)* 65 60 Paraffin-impregnated Venous leg ulcer
gauze (USA), saline
solution/betadine-
impregnated gauze
(UK) + ZnO paste &
compression bandage
Kim et al17 1996 Korea 44 44 23:3 13:5 50.5 ( 18.3 46.9 ( 16.8 Wet saline gauze Pressure ulcer
Hansson18 1998 Sweden, 97 97 NS NS NS NS Paraffin gauze Venous leg ulcer
Denmark,
NL, UK
Viciano et al6 2000 Spain 38 38 31:7 (whole group)* 24 (whole group) Gauze with povidone Excised pilonidal
iodine sinus wound
Srivastava et al Unpub- India 100 100 17:3 (whole group)* 39.7 43 Paraffin gauze Venous leg ulcer
(written communi- lished
cation, January 2001)
*Ratio not given separately for the two groups. N = total number of ulcers in both groups; n = total number of patients in both groups;
SD = standard deviation; CON = conventional dressing; HCD = hydrocolloid dressing; NS = not stated; NL = the Netherlands.
Discussion
Wounds are structural or physiological disruptions of the
integument. Chronic wounds do not heal within an expected
time frame and may linger for weeks, months or years. Authors
differ in the definition of chronic wounds but, in general,
wounds requiring more than 6 weeks to heal are labelled chronic.
Management of chronic wounds is a common problem in
health care. HCDs have been promoted as an effective method
for healing chronic wounds. Immediate benefits include a
moist, warm, hypoxic and contamination-free environment
that promotes wound healing.3–5 Moreover, patients require
fewer outpatient visits and mobility increases markedly as the
dressing is left in situ for 7–10 days and is changed only when
it leaks. Since HCD is semi-permeable, patients can take regu-
lar baths or even swim without the need for a dressing change.
The trials reported in the literature give differing opinions
regarding the efficacy of HCD. The results vary from no or
minimal benefit to significant benefit with HCD compared
with conventional dressing.
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We therefore embarked on this meta-analysis to confirm
the known theoretical advantages of HCD and to arrive at a
meaningful conclusion. Bradley et al published a systematic
review of wound care management in 1999.19 The dressings
and topical agents compared were topical aloe vera, topical
insulin, topical ketanserine, topical allopurinol, topical
dimethysulfoxide, topical hyaluronic acid, buffered acidified
ointment, cryopreserved cultured allografts, wet-to-dry
dressings, different HCDs, collagen sponges, foam dressing,
alginate dressing and zinc oxide-impregnated stockinette. The
authors compared HCD and traditional dressings separately
for pressure sores, venous ulcers and arterial ulcers. Five trials
(six reports) (r2 = 5.76, df = 4) indicated that HCD increased
the odds of healing pressure ulcers by threefold (OR = 2.57;
95% CI = 1.58,4.18).9,12,14,20,21 Nine trials compared HCD with
traditional dressings for venous leg ulcers, yielding a pooled
OR of 1.4 (95% CI = 0.83, 2.34).11,16,22–28 One trial by Gibson
and co-workers compared HCD dressing with knitted viscose
dressing for arterial leg ulcers.29 There was no difference in
healing rates.
Figure 2. Forrest plot of the risk difference (RD) of complete healing of wounds, comparing conventional (Conv) to hydrocolloid dressing (HCD).
Figure 1. Forrest plot of the odds ratio (OR) of complete healing of wounds, comparing conventional (Conv) to hydrocolloid dressing (HCD).
Study HCD Conv Total OR  95% CI p
Gorse & Messner10 54/76 26/52 128 2.45 1.18 5.12 0.02
Backhouse et al11 21/28 22/28 56 0.82 0.24 2.84 0.75
Alm et al9 17/31 4/25 56 6.37 1.77 22.98 0.00
Xakellis & Chrischilles12 16/18 18/21 39 1.33 0.20 9.02 0.77
Cordts et al13 8/23 6/20 43 1.24 0.34 4.50 0.74
Colwell et al14 11/48 1/49 97 14.27 1.76 115.55 0.00
Ohlsson et al15 7/14 2/14 28 6.00 0.97 37.30 0.04
Arnold et al16 11/46 14/47 93 0.74 0.29 1.86 0.52
Kim et al17 21/26 14/18 44 1.20 0.27 5.26 0.81
Hansson18 5/48 7/49 97 0.70 0.21 2.37 0.56
Viciano et al6 17/23 11/15 38 1.03 0.24 4.50 0.97
Srivastava et al 33/50 23/50 100 2.28 1.02 5.11 0.04
Fixed combined 221/431 148/388 819 1.72 1.23 2.41 0.00
Random combined 221/431 148/388 819 1.73 1.08 2.78 0.02
Q value of heterogeneity = 18.77, p = 0.06
0.01 0.1 1 10 100
 Favours Conv Favours HCD
Study HCD Conv Total RD  95% CI P
Gorse & Messner10 54/76 26/52 128 0.21 0.04 0.38 0.02
Backhouse et al11 21/28 22/28 56 –0.04 –0.26 0.19 0.75
Alm et al9 17/31 4/25 56 0.39 0.16 0.61 0.00
Xakellis & Chrischilles12 16/18 18/21 39 0.03 –0.18 0.24 0.77
Cordts et al13 8/23 6/20 43 0.05 –0.23 0.33 0.74
Colwell et al14 11/48 1/49 97 0.21 0.08 0.33 0.00
Ohlsson et al15 7/14 2/14 28 0.36 0.04 0.68 0.04
Arnold et al16 11/46 14/47 93 –0.06 –0.24 0.12 0.52
Kim et al17 21/26 14/18 44 0.03 –0.21 0.27 0.81
Hansson18 5/48 7/49 97 –0.04 –0.17 0.09 0.56
Viciano et al6 17/23 11/15 38 0.01 –0.28 0.29 0.97
Srivastava et al 33/50 23/50 100 0.20 0.01 0.39 0.04
Fixed combined 221/431 148/388 819 0.10 0.05 0.16 0.00
Random combined 221/431 148/388 819 0.11 0.02 0.19 0.02
Q value of heterogeneity = 24.32, p = 0.01
–1.00 –0.50 0.00 0.50 1.00
 Favours Conv Favours HCD
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The review of Bradley et al included randomized trials
irrespective of date, language and publication status if they
were conducted on humans, as well as data from magazines
and conference proceedings.19 The trials in this review that did
not meet our inclusion criteria were excluded from our meta-
analysis.
Of the 12 studies in our meta-analysis, two large studies
(one of which was the unpublished Srivastava et al study)
showed that HCD was better than conventional dressing for
ulcer healing.10 Three smaller studies reported a significantly
favourable outcome with HCDs.9,14,15 The other seven studies
could not arrive at a conclusion. Meta-analysis of the 12 trials
revealed that HCD was significantly better than conventional
dressing in terms of complete healing of ulcers.
The studies had several limitations: the randomization
method to treatment and control groups was not described.
Observers were not blinded. Heterogeneity among the partici-
pants might have had a bearing on the overall result of the
meta-analysis, e.g. presence of diabetes, arterial or venous dis-
ease, infection and concomitant medication such as steroid
or immunosuppressive therapy may be detrimental to healing
and, hence, affect the outcome. The most important limita-
tion was the small sample size of most of the studies that
precluded the authors from arriving at a conclusion. More
than one ulcer from one patient was included in some tri-
als.10,12,14,16 In these trials, patients’ intrinsic factors might
have created a bias on healing of all the ulcers.
Recommendations
Larger studies that include significant numbers of common
types of ulcers, i.e. venous leg ulcer, decubitus ulcer and dia-
betic foot ulcer, are required to draw a significant conclusion
with greater power and confidence. The number of patients
should be based on prior sample size calculation. Studies
should report the outcome as complete healing, which is more
important from the patient’s point of view than percentage
reduction in ulcer area, and the time to healing (to facilitate
future meta-analysis by survival analysis). In addition, only
one reference wound should be taken from each patient.
Observers should be blinded to ensure that outcome measure-
ments are completely objective. For evaluation of cost, stan-
dard criteria should be adopted to maintain uniformity.
Where possible, investigators should join a large group
such as the Cochrane Collaboration or Clinical Trials Unit of
Oxford University or International Committee on Wound
Management for uniformity in study design and conduct.
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